Skip to main content
Erschienen in: Surgery Today 1/2013

01.01.2013 | Original Article

Laparoscopic surgery minimizes the surgical manipulation of isolated tumor cells leading to decreased metastasis compared to open surgery for colorectal cancer

verfasst von: Sayuri Akiyoshi, Koshi Mimori, Tomoya Sudo, Fumiaki Tanaka, Kohei Shibata, Masaki Mori

Erschienen in: Surgery Today | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Purposes

We focused on the possible benefits of laparoscopic surgery to protect against isolated tumor cells (ITC) generated by surgical manipulation in comparison to open surgery.

Methods

We performed conventional open surgery and laparoscopic surgery for 25 and 8 cases of colorectal cancer (CRC), respectively. We compared the presence of ITC in the peripheral blood (PB) immediately after surgery via quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for a representative epithelial marker, carcinoembryonic antigen (CEA).

Results

In the 25 patients who underwent open surgery, 8 of the 10 cases with metastasis were positive for ITC in PB, while 13 of the 15 cases without metastasis were negative for ITC. Therefore, we validated that there was a significant clinical usefulness for the detection of ITC in the prediction of metastasis (p = 0.0024). We limited our subsequent analysis to the CRC cases with a Dukes stage of B or C to avoid differences due to the background, and we found that the positive ITC rate for metastasis was higher in the 19 patients who underwent open surgery (42.1 %) than in the 8 who underwent laparoscopic surgery (37.5 %).

Conclusions

The short observation period, especially in the laparoscopic surgery group, and the inadequate number of cases limit the ability to draw any definitive conclusions; however, laparoscopic surgery appears to minimize the surgical manipulation, thus leading to reduced ITC from primary CRC compared with open surgery.
Literatur
1.
Zurück zum Zitat Inomata M, Yasuda K, Shiraishi N, Kitano S. Clinical evidences of laparoscopic versus open surgery for colorectal cancer. Jpn J Clin Oncol. 2009;39:471–7.PubMedCrossRef Inomata M, Yasuda K, Shiraishi N, Kitano S. Clinical evidences of laparoscopic versus open surgery for colorectal cancer. Jpn J Clin Oncol. 2009;39:471–7.PubMedCrossRef
2.
Zurück zum Zitat Kitano S, Inomata M. Is laparoscopic surgery acceptable for advanced colon cancer? Cancer Sci. 2009;100:567–71.PubMedCrossRef Kitano S, Inomata M. Is laparoscopic surgery acceptable for advanced colon cancer? Cancer Sci. 2009;100:567–71.PubMedCrossRef
3.
Zurück zum Zitat Fleshman J, Sargent DJ, Green E, Anvari M, Stryker SJ, Beart RW Jr, et al. Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST study group trial. Ann Surg. 2007;246:655–62. discussion 62–4.PubMedCrossRef Fleshman J, Sargent DJ, Green E, Anvari M, Stryker SJ, Beart RW Jr, et al. Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST study group trial. Ann Surg. 2007;246:655–62. discussion 62–4.PubMedCrossRef
4.
Zurück zum Zitat Stocchi L, Nelson H, Young-Fadok TM, Larson DR, Ilstrup DM. Safety and advantages of laparoscopic vs. open colectomy in the elderly: matched-control study. Dis Colon Rectum. 2000;43:326–32.PubMedCrossRef Stocchi L, Nelson H, Young-Fadok TM, Larson DR, Ilstrup DM. Safety and advantages of laparoscopic vs. open colectomy in the elderly: matched-control study. Dis Colon Rectum. 2000;43:326–32.PubMedCrossRef
5.
Zurück zum Zitat Hayashi N, Egami H, Kai M, Kurusu Y, Takano S, Ogawa M. No-touch isolation technique reduces intraoperative shedding of tumor cells into the portal vein during resection of colorectal cancer. Surgery. 1999;125:369–74.PubMedCrossRef Hayashi N, Egami H, Kai M, Kurusu Y, Takano S, Ogawa M. No-touch isolation technique reduces intraoperative shedding of tumor cells into the portal vein during resection of colorectal cancer. Surgery. 1999;125:369–74.PubMedCrossRef
6.
Zurück zum Zitat Galan M, Vinolas N, Colomer D, Soler G, Munoz M, Longaron R, et al. Detection of occult breast cancer cells by amplification of CK19 mRNA by reverse transcriptase-polymerase chain reaction: role of surgical manipulation. Anticancer Res. 2002;22:2877–84.PubMed Galan M, Vinolas N, Colomer D, Soler G, Munoz M, Longaron R, et al. Detection of occult breast cancer cells by amplification of CK19 mRNA by reverse transcriptase-polymerase chain reaction: role of surgical manipulation. Anticancer Res. 2002;22:2877–84.PubMed
7.
Zurück zum Zitat Mori M, Mimori K, Ueo H, Karimine N, Barnard GF, Sugimachi K, et al. Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. Int J Cancer. 1996;68:739–43.PubMedCrossRef Mori M, Mimori K, Ueo H, Karimine N, Barnard GF, Sugimachi K, et al. Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. Int J Cancer. 1996;68:739–43.PubMedCrossRef
8.
Zurück zum Zitat Mori M, Mimori K, Inoue H, Barnard GF, Tsuji K, Nanbara S, et al. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res. 1995;55:3417–20.PubMed Mori M, Mimori K, Inoue H, Barnard GF, Tsuji K, Nanbara S, et al. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res. 1995;55:3417–20.PubMed
9.
Zurück zum Zitat Mori M, Mimori K, Ueo H, Tsuji K, Shiraishi T, Barnard GF, et al. Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas. J Clin Oncol. 1998;16:128–32.PubMed Mori M, Mimori K, Ueo H, Tsuji K, Shiraishi T, Barnard GF, et al. Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas. J Clin Oncol. 1998;16:128–32.PubMed
10.
Zurück zum Zitat Mimori K, Kataoka A, Yamaguchi H, Masuda N, Kosaka Y, Ishii H, et al. Preoperative u-PAR gene expression in bone marrow indicates the potential power of recurrence in breast cancer cases. Ann Surg Oncol. 2009;16:2035–41.PubMedCrossRef Mimori K, Kataoka A, Yamaguchi H, Masuda N, Kosaka Y, Ishii H, et al. Preoperative u-PAR gene expression in bone marrow indicates the potential power of recurrence in breast cancer cases. Ann Surg Oncol. 2009;16:2035–41.PubMedCrossRef
11.
Zurück zum Zitat Mimori K, Fukagawa T, Kosaka Y, Kita Y, Ishikawa K, Etoh T, et al. Hematogenous metastasis in gastric cancer requires isolated tumor cells and expression of vascular endothelial growth factor receptor-1. Clin Cancer Res. 2008;14:2609–16.PubMedCrossRef Mimori K, Fukagawa T, Kosaka Y, Kita Y, Ishikawa K, Etoh T, et al. Hematogenous metastasis in gastric cancer requires isolated tumor cells and expression of vascular endothelial growth factor receptor-1. Clin Cancer Res. 2008;14:2609–16.PubMedCrossRef
12.
Zurück zum Zitat Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, et al. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice. Cancer Res. 2005;65:7775–81.PubMed Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, et al. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice. Cancer Res. 2005;65:7775–81.PubMed
13.
Zurück zum Zitat Mimori K, Fukagawa T, Kosaka Y, Ishikawa K, Iwatsuki M, Yokobori T, et al. A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases. Ann Surg Oncol. 2008;15:2934–42.PubMedCrossRef Mimori K, Fukagawa T, Kosaka Y, Ishikawa K, Iwatsuki M, Yokobori T, et al. A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases. Ann Surg Oncol. 2008;15:2934–42.PubMedCrossRef
14.
Zurück zum Zitat Mimori K, Ueo H, Shirasaka C, Mori M. Clinical significance of MT1-MMP mRNA expression in breast cancer. Oncol Rep. 2001;8:401–3.PubMed Mimori K, Ueo H, Shirasaka C, Mori M. Clinical significance of MT1-MMP mRNA expression in breast cancer. Oncol Rep. 2001;8:401–3.PubMed
Metadaten
Titel
Laparoscopic surgery minimizes the surgical manipulation of isolated tumor cells leading to decreased metastasis compared to open surgery for colorectal cancer
verfasst von
Sayuri Akiyoshi
Koshi Mimori
Tomoya Sudo
Fumiaki Tanaka
Kohei Shibata
Masaki Mori
Publikationsdatum
01.01.2013
Verlag
Springer Japan
Erschienen in
Surgery Today / Ausgabe 1/2013
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-012-0389-0

Weitere Artikel der Ausgabe 1/2013

Surgery Today 1/2013 Zur Ausgabe

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 24 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Metformin rückt in den Hintergrund

24.04.2024 DGIM 2024 Kongressbericht

Es hat sich über Jahrzehnte klinisch bewährt. Doch wo harte Endpunkte zählen, ist Metformin als alleinige Erstlinientherapie nicht mehr zeitgemäß.

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.